paclitaxel liposome injection
Sponsors
Nanjing Luye Sike Pharmaceutical Co., Ltd.
Conditions
Breast CancerSolid Tumors
Phase 4
Dose Escalation and Pharmacokinetic Study of Paclitaxel Liposome Injection in Treating Patients With Advanced Solid Tumor After Failure From Conventional Treatments
NCT01994031
Start: 2014-08-31Target: 36Updated: 2014-08-27
Weekly and Every 3 Week Administration of Paclitaxel Liposome Injection in Metastatic Breast Cancer
NCT02142790
Start: 2014-05-31Target: 120Updated: 2014-07-22